Factor-H and Skyhawk Therapeutics collaborate to Support Responsible Communication on the Falcon-HD Clinical Trial in Latin America

Factor-H and Skyhawk Therapeutics collaborate to Support Responsible Communication on the Falcon-HD Clinical Trial in Latin America

A central priority for Factor-H is ensuring that information about clinical research is shared in a way that does not create unrealistic expectations or add to the emotional burden faced by individuals and families affected by Huntington’s disease. While scientific progress is essential and provides reasons for optimism, it is…
Hope in Numbers: More than 2,000 people from the Huntington’s community in Venezuela benefited from Factor-H programs during the third quarter of 2025

Hope in Numbers: More than 2,000 people from the Huntington’s community in Venezuela benefited from Factor-H programs during the third quarter of 2025

During the third quarter of 2025, Factor-H, in partnership with Hábitat Luz, expanded its impact in the communities of San Luis and Barranquitas, reaching a total of 2,045 people, including individuals with Huntington’s disease (HD), their families, and children from the Abrazos Program.
To the Rhythm of the veda - Al ritmo de la veda

To the Rhythm of the veda - Al ritmo de la veda

At first, going to Barranquitas felt like stepping into the world of Mad Max. The heat, the dust, the precariousness, the sense that everything could fall apart at any moment. But over time, something shifted. Maybe it was accepting my mission—to help and inspire. Maybe it was realizing that in…
AMT-130 Marks a Historic Moment for Huntington’s—Now Comes Careful Communication

AMT-130 Marks a Historic Moment for Huntington’s—Now Comes Careful Communication

On July 10, 2024, I wrote a reflection piece following the investor conference where uniQure presented the encouraging 24-month results of AMT-130, the first HTT-directed gene therapy delivered directly into the brain regions most severely affected by mutant huntingtin —the caudate and putamen. At that time, early evidence suggested the…
Ignacio Muñoz-Sanjuan: “We may see a Huntington’s therapy approved in 2026. It is a day for hope: while the therapy will at first be limited, access will increase in the years ahead”

Ignacio Muñoz-Sanjuan: “We may see a Huntington’s therapy approved in 2026. It is a day for hope: while the therapy will at first be limited, access will increase in the years ahead”

24/09/2025 Ignacio Muñoz-Sanjuan, neuroscientist and founder of the non-profit Factor-H, has expressed optimism that an experimental gene therapy for Huntington’s disease, developed by uniQure and called AMT-130, could receive regulatory approval in the first half of 2026, in what is a very significant milestone for patients and families affected by…
Medical Outreach in San Luis: Over 100 Beneficiaries

Medical Outreach in San Luis: Over 100 Beneficiaries

On July 19, Factor H hosted a Medical Outreach event in San Luis, Venezuela, for people living with Huntington’s disease and those at risk of developing it. More than 100 individuals received comprehensive care—something that would not have been possible without the incredible commitment of 40 volunteers and partners. The…
Um dia de saúde abrangente para crianças e adolescentes em Santa Marta, Colômbia

Um dia de saúde abrangente para crianças e adolescentes em Santa Marta, Colômbia

Santa Marta, 10 de maio de 2025 Como parte do Programa Abrazos, a Factor-H realizou um dia especial dedicado às crianças e adolescentes afetados direta ou indiretamente pela doença de Huntington, sob o tema "Cuidar de você é minha prioridade". A atividade, realizada em 10 de maio na cidade de Santa Marta, teve como foco...
2025 Dia da Gratidão - um resumo dos eventos na Venezuela

2025 Dia da Gratidão - um resumo dos eventos na Venezuela

O Dia da Gratidão ocorreu em 23 de março de 2025 e culminou uma semana de eventos na Venezuela para homenagear as contribuições das famílias venezuelanas para o avanço da ciência e da medicina. A Factor-H, trabalhando em conjunto com a Habitat LUZ, voluntários da comunidade e profissionais de saúde, organizou uma série de eventos que...
O Programa de Assistência Jurídica na Colômbia

O Programa de Assistência Jurídica na Colômbia

A Factor-H oferece um serviço de assistência jurídica gratuita na Colômbia, com o único objetivo de facilitar o acesso aos serviços, medicamentos e insumos que o Estado colombiano garante a todos os pacientes afetados pela doença de Huntington. O Factor-H tem como objetivo ajudar todas as famílias com EH...
A Factor-H recebe o Prêmio Amgen 2024!

A Factor-H recebe o Prêmio Amgen 2024!

O programa de cuidadores da Factor-H 'La Luz' ganha o prêmio Amgen/MIT Solve 2024 na Concordia Summit Estamos extremamente honrados e honrados com esse prêmio, que financiará nosso programa de apoio a cuidadores na Venezuela. O dinheiro do prêmio será usado para financiar um programa de treinamento de cuidadores, apoiar o acompanhamento psicológico e...